Barcelona snapshots

Prof. Antoni Gual

Antoni Gual psychiatrist Controversies Psiquiatry Barcelona
Institute of Neuroscience, Hospital Clinic Barcelona, Spain
Talk Prevention of substance abuse in mental health settings
Date Thursday, September 16th, 2021
Time 19:00 - 19:45
Round Table 2. Addictions


Dr Antoni Gual is a psychiatrist, Emeritus Researcher at IDIBAPS, and former Head of the Addictions Unit at the Neurosciences Institute, Clinic Hospital, University of Barcelona, Spain, and also acts as Alcohol Consultant at the Health Department of Catalonia. He has coordinated several EU funded projects in the field of addictions and has also been PI of several pharmacological clinical trials. He has published more than 150 articles in peer reviewed journals and edited several books.

He is Vicepresident of the International Network on Brief Interventions for Alcohol Problems (INEBRIA), past-President of the European Federation of Addiction Scientific Societies (EUFAS) and past-President of the Spanish Scientific Society for the Study of Alcohol and Alcoholism.

Over the years he has been involved in several clinical trials for the treatment of addictions. Amongst them, he was PI in the pivotal spanish study on acamprosate, and researcher in RCT trials conducted with naltrexone, tiapride, bromocriptine, sertraline and mavoglurant. He was PI in the spanish sodium oxibate RCT, and in one of the pivotal trials of nalmefene (Esense 2).

In the field of brief interventions, Dr Gual has been involved in the development of the Catalan program on brief interventions in PHC since its creation in 1995, and has developed also brief motivational interventions in the Emergency Room. He has participated in several EU funded studies focusing on Brief Interventions (Smart, Bistairs, EWA, Scala), being project coordinator in some of them (Phepa, Amphora, Odhin, Deep Seas).